Starbucks makes it into Josh Brown's Best Stocks list as turnaround gains steam

Net revenues grew 6% YoY in the latest quarter with U.S. comparable sales +4% and international sales +5%, while China same-store sales declined 14% in 2024 and North American traffic fell 10% in 2024. New CEO Brian Niccol targets a 'Back to Starbucks' turnaround with a goal of global comp sales growth of 3%+ (U.S. matching in 2026) and margin expansion via menu simplification and operational fixes; technically SBUX cleared the $100 pivot with 50-day support near $94–95 and 200-day near $89, leaving upside toward ~$120 if the breakout holds.

Analysis

The recent move in SBUX appears less like a pure demand shock and more like the market re-pricing a visible operating pivot into a higher-margin model; management’s playbook (menu simplification, throughput fixes, and store experience) can drive 150–250bps of incremental operating margin over 12–18 months if executed, which in many retail roll-ups is sufficient to re-rate multiples even with only mid-single-digit organic revenue growth. The China divestiture is a lever with asymmetric outcomes: a clean sale that de-risks cash flow volatility and funds buybacks/repairs accelerates multiple expansion, while a drawn-out or value-choppy process creates a multi-quarter headwind and gives competitors room to consolidate share.

Second-order competitive dynamics favor channel owners who can monetize on-the-go coffee at scale (convenience stores, QSR breakfast menus, and ready-to-drink CPG partners) because they capture marginal trips Starbucks loses during tighter consumer budgets; conversely, Starbucks’ recovery would tighten the margin squeeze on value players because it can selectively reclaim frequency through loyalty and product tiering. Labor and unionization remain wildcard inputs to unit economics — even modest incremental hourly cost increases concentrated in dense urban markets can flip store-level payback curves and slow new store openings, turning a margin recovery into a capitalization story instead.

Timescales matter: technical interest and short-term momentum can carry the stock for weeks, but fundamental evidence that matters to multi-strategy portfolios will be 1) a repeatable sequential improvement in U.S. transactions over two more quarters, 2) clear capital allocation actions (buybacks/dividends) from China sale proceeds within 6–12 months, and 3) stabilization or retreat in wage inflation pressures. Absent one of those, the rerating is vulnerable to a 3–6 month reversal as investors re-assess durable growth versus a convenience/defensive reclassification.

Key Decisions for Investors

• Core overweight SBUX (6–12 month horizon): accumulate on pullbacks up to a 10–15% drawdown from entry, target 30–40% upside if management posts sequential operating-margin improvement and redeploys China proceeds; hard stop if shares decline >18% from entry or execution misses on two consecutive quarters.
• Defined-risk options: buy a 12-month SBUX call spread (buy near-the-money, sell 1.5–2x strike) sized to produce ~2.5x potential return if the company delivers the margin lift and buyback cadence; max loss = premium paid, horizon tied to next two quarterly prints plus China sale timeline.
• Event-driven allocation: size a catalyst bucket to add on a price gap higher following a confirmed China-sale binding agreement that allocates >50% proceeds to buybacks/dividends; trim into that move — aim to harvest 25–35% of the position if headline multiple expansion occurs within 30 trading days.
• Hedge/insurance: purchase short-dated puts (6–9 weeks) sized at ~15% notional of the long exposure ahead of each quarterly report to protect against a surprise re-acceleration of traffic declines or adverse labor headlines — acceptable insurance cost up to 1–2% of position value per quarter.